Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA grants orphan drug designation to Stealth BioTherapeutics' elamipretide for PMM

Oct. 3, 2017

JCR seeks Japanese approval for JR-051 for Fabry disease

Oct. 2, 2017

ViaCyte obtains another CIRM grant to support development of PEC-Direct product candidate

Oct. 2, 2017

FDA approves Novo Nordisk's Fiasp

Oct. 2, 2017

Eidos Therapeutics doses first cohort in AG-10 phase I study

Sep. 29, 2017

Diamyd to design first clinical trial of Remygen

Sep. 29, 2017

MSD announces approval of Atozet Tablets in Japan

Sep. 28, 2017

FDA issues complete response letter for Intarcia's ITCA-650

Sep. 28, 2017

Hanmi presents data on HM-15136 for CHI treatment

Sep. 28, 2017

Ascendis Pharma begins dosing in phase I study of TransCon PTH

Sep. 28, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...